Davis Polk advised the joint book-running managers in connection with the $180 million initial public offering of common stock of Beam Therapeutics Inc. The common stock is listed on the…
Davis Polk advised Clarivate Analytics Plc in connection with the $559 million SEC-registered offering of 27,600,000 of its ordinary shares. The ordinary shares are listed on the New York…
Davis Polk advised the joint book-running managers and representatives of the underwriters on an SEC-registered offering by Stanley Black & Decker, Inc. of $750 million aggregate…
Davis Polk advised the underwriter in connection with the $59.9 million secondary offering of 2,678,049 shares of common stock of TriState Capital Holdings, Inc. by selling shareholders LM…
Davis Polk advised the initial purchasers on a Rule 144A and Regulation S offering of $300 million aggregate principal amount of 8.875% senior notes due 2025 of Credivalores–Crediservicios…
Davis Polk advised the joint book-running managers and representatives of the initial purchasers on a Rule 144A offering by Integra LifeSciences Holdings Corporation of $575 million…
Davis Polk advised the joint bookrunners in connection with the initial public offering by Mitre Realty Empreendimentos e Participações S.A. and the selling shareholder of 54,545,454 common…
Davis Polk advised Morgan Stanley in connection with its SEC-registered global offering of CAD1 billion aggregate principal amount of floating-rate senior notes due 2023. The notes, which…
Davis Polk advised Reynolds Consumer Products Inc. on its $1.4 billion initial public offering of 54,245,500 shares of common stock, which includes the full exercise of the underwriters’…
Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with the $281.75 million initial public offering by 1Life Healthcare, Inc…